Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Clin Cancer Res. 2016 Jun 21;22(24):6039–6050. doi: 10.1158/1078-0432.CCR-16-0471

Table 2. Patient Characteristics.

Affymetrix Dataset Agilent Dataset Total
Characteristic n=1033 (%) n=386 (%) n=1419 (%)
Age
 <50 461 (49) 116 (52) 577 (49)
 >50 488 (51) 108 (48) 596 (51)
Histologic Grade
 Grade: 1 60 (7) 29 (8) 89 (7)
 Grade: 2 347 (40) 178 (49) 525 (42)
 Grade: 3 469 (54) 156 (43) 625 (50)
ER Status
 ER pos 508 (49) 218 (58) 726 (52)
 ER neg 521 (51) 160 (42) 681 (48)
HER2 Status
 HER2 pos 135 (12) 72 (20) 207 (14)
 HER2 neg 993 (88) 292 (80) 1285 (86)
Clinical Subtype
 ER 465 (49) 183 (48) 648 (49)
 HER2 135 (14) 91 (24) 226 (17)
 TNBC 340 (36) 106 (28) 446 (34)
PAM50 Subtype
 LumA 280 (27) 108 (28) 388 (27)
 LumB 197 (19) 82 (21) 279 (20)
 Her2 124 (12) 38 (10) 162 (11)
 Normal 95 (9) 48 (12) 143 (10)
 Basal 337 (33) 110 (28) 447(32)
Anthracycline
 Anthracycline: Yes 970 (94) 250 (65) 1220 (86)
 Anthracycline: No 63 (6) 134 (35) 197 (14)
Alkylator
 Alkylator: Yes 1037 (93) 160 (42) 1197 (80)
 Alkylator: No 84 (7) 224 (56) 308 (20)
Taxane
 Taxane: Yes 765 (74) 291 (76) 1056 (75)
 Taxane: No 268 (26) 93 (24) 361 (25)
Combination Chemotherapy
 Anthra + Tax +/- Alk 722 (76) 156 (45) 156 (41)
 Anthra +/- Alk 183 (19) 53 (15) 57 (15)
 Taxane Only 43 (5) 4 (1) 136 (35)
 Anthtra + Plat 0 136 (39) 35 (9)

Abbreviations: Anthra, Anthracycline; Tax, Taxane; Alk, Alkylator; Plat, Platinum.